news_6

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care Test SARASOTA, Fla.--(BUSINESS WIRE)--#ASX--Lumos Diagnostics...

news_6

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care Test SARASOTA, Fla.--(BUSINESS WIRE)--#ASX--Lumos Diagnostics...

generic_link-32

HKDC Welcomes Chief Executive’s Proposal to set up a New Culture, Sports and Tourism Bureau to Develop Hong Kong as a Centre for International Cultural Exchange in Policy Address